These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 32252747

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
    Aris P, Boroumand MA, Rahbar M, Douraghi M.
    Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical and bacteriological efficacy of amikacin in the treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Ipekci T, Seyman D, Berk H, Celik O.
    J Infect Chemother; 2014 Dec; 20(12):762-7. PubMed ID: 25179392
    [Abstract] [Full Text] [Related]

  • 8. Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study.
    Demonchy E, Courjon J, Ughetto E, Durand M, Risso K, Garraffo R, Roger PM.
    Int J Antimicrob Agents; 2018 Jun; 51(6):836-841. PubMed ID: 29378342
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Causative Bacterial Strains and Sensitivityto Antimicrobial Agents in Female Acute Uncomplicated Cystitis].
    Owari T, Yamamoto T, Mizobuchi S, Itami Y, Nakahama T, Matsumoto Y, Yamada K, Momose H.
    Hinyokika Kiyo; 2017 May; 63(5):189-193. PubMed ID: 28625025
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical results of lividomycin in urinary tract infections].
    Saito I.
    Jpn J Antibiot; 1972 Dec; 25(6):396-8. PubMed ID: 4579559
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activity of fosfomycin and other antimicrobials against uropathogenic Escherichia coli and Klebsiella pneumoniae at a tertiary care center in Lebanon.
    Araj GF, Jaber FA.
    J Med Liban; 2012 Dec; 60(3):142-7. PubMed ID: 23198454
    [Abstract] [Full Text] [Related]

  • 20. Chronological change of antibiotic use and antibiotic resistance in Escherichia coli causing urinary tract infections.
    Shigemura K, Tanaka K, Adachi M, Yamashita M, Arakawa S, Fujisawa M.
    J Infect Chemother; 2011 Oct; 17(5):646-51. PubMed ID: 21487942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.